IPO watch - Companies with IPO lockup periods expiring during the week for certain blocks of shares include Kairos Pharma ( ...
We recently published a list of 10 Best Healthcare Stocks For Long-Term Investment. In this article, we are going to take a ...
The Bromobenzene market is driven by increasing applications in pharmaceuticals and chemical manufacturing, alongside rising demand for specialty chemicals.Austin, March 14, 2025 (GLOBE NEWSWIRE) -- ...
In a report released today, Joon Lee from Truist Financial reiterated a Buy rating on Catalyst Pharma (CPRX – Research Report). The company’s ...
Eli Lilly just scored a major win with its Phase 3 BRAVE-AA-PEDS study. The trial confirmed baricitinib's effectiveness in ...
(Sharecast News) - London stocks had extended gains by midday on Friday as investors mulled an unexpected contraction in the UK economy in January. The FTSE was up 0.6% at 8,593.51 .
Citi said SMid biotech sentiment has been more challenged than expected in early 2025, largely due to investor focus on ...
Citi initiated coverage of Kiniksa (KNSA) with a Buy rating and $40 price target Healthcare policy remains a key biopharma sector uncertainty ...
This was the stock's second consecutive day of gains.
In the US, healthcare expenditures and costs have been increasing. According to the Centers for Medicare & Medicaid Services, ...
Shri Amit Agrawal highlighted the rapid expansion of the sector, emphasizing India’s growing role in research and innovation.